CA2500558A1 - Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril - Google Patents

Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril Download PDF

Info

Publication number: CA2500558A1
Authority: CA; Canada
Prior art keywords: compound; group; acid; formula; organic solvent
Prior art date: 2005-03-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002500558A

Other languages

English (en)

Inventor

Daqing Che

Bhaskar Reddy Guntoori

Yajun Zhao

Nadia Corelli-Rennie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Apotex Pharmachem Inc

Original Assignee

Apotex Pharmachem Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-10

Filing date

2005-03-10

Publication date

2006-09-10

2005-03-10 Application filed by Apotex Pharmachem Inc filed Critical Apotex Pharmachem Inc

2005-03-10 Priority to CA002500558A priority Critical patent/CA2500558A1/fr

2006-09-10 Publication of CA2500558A1 publication Critical patent/CA2500558A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 52
238000002360 preparation method Methods 0.000 title claims abstract description 16
125000002619 bicyclic group Chemical group 0.000 title description 7
HHHKFGXWKKUNCY-FHWLQOOXSA-N cilazapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N2[C@@H](CCCN2CCC1)C(O)=O)=O)CC1=CC=CC=C1 HHHKFGXWKKUNCY-FHWLQOOXSA-N 0.000 title description 6
229960005025 cilazapril Drugs 0.000 title description 6
150000001875 compounds Chemical class 0.000 claims abstract description 43
239000003960 organic solvent Substances 0.000 claims abstract description 27
125000006239 protecting group Chemical group 0.000 claims abstract description 24
125000000217 alkyl group Chemical group 0.000 claims abstract description 23
125000003118 aryl group Chemical group 0.000 claims abstract description 21
239000001257 hydrogen Substances 0.000 claims abstract description 20
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 20
125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 12
238000010992 reflux Methods 0.000 claims abstract description 12
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 11
125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 8
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 39
229910052717 sulfur Inorganic materials 0.000 claims description 26
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
239000000203 mixture Substances 0.000 claims description 17
150000007524 organic acids Chemical class 0.000 claims description 13
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 12
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 12
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 12
-1 acyclic amide Chemical class 0.000 claims description 10
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
238000007363 ring formation reaction Methods 0.000 claims description 10
239000011877 solvent mixture Substances 0.000 claims description 7
125000004122 cyclic group Chemical group 0.000 claims description 6
238000002156 mixing Methods 0.000 claims description 6
MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 claims description 5
239000005711 Benzoic acid Substances 0.000 claims description 5
235000010233 benzoic acid Nutrition 0.000 claims description 5
150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
230000003197 catalytic effect Effects 0.000 claims description 5
238000006243 chemical reaction Methods 0.000 claims description 5
150000002576 ketones Chemical class 0.000 claims description 5
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
239000003849 aromatic solvent Substances 0.000 claims description 4
ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical group CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 claims description 4
230000003213 activating effect Effects 0.000 claims description 3
238000010511 deprotection reaction Methods 0.000 claims description 3
AGJSNMGHAVDLRQ-HUUJSLGLSA-N methyl (2s)-2-[[(2r)-2-[[(2s)-2-[[(2r)-2-amino-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,3-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoate Chemical compound SC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(=O)N[C@@H](CCSC)C(=O)OC)CC1=CC=C(O)C(C)=C1C AGJSNMGHAVDLRQ-HUUJSLGLSA-N 0.000 claims description 3
239000007825 activation reagent Substances 0.000 claims description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
239000007787 solid Substances 0.000 description 11
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 11
150000002431 hydrogen Chemical class 0.000 description 10
OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 9
239000002904 solvent Substances 0.000 description 9
239000000047 product Substances 0.000 description 8
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
235000001014 amino acid Nutrition 0.000 description 7
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
150000001413 amino acids Chemical class 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
BZIBRGSBQKLEDC-UHFFFAOYSA-N diazinane-3-carboxylic acid Chemical compound OC(=O)C1CCCNN1 BZIBRGSBQKLEDC-UHFFFAOYSA-N 0.000 description 5
150000002148 esters Chemical class 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 description 5
239000011541 reaction mixture Substances 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
238000001914 filtration Methods 0.000 description 4
XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
LCEFEIBEOBPPSJ-UHFFFAOYSA-N phenyl selenohypobromite Chemical compound Br[Se]C1=CC=CC=C1 LCEFEIBEOBPPSJ-UHFFFAOYSA-N 0.000 description 3
UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 3
125000005544 phthalimido group Chemical group 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
239000002253 acid Substances 0.000 description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
150000005840 aryl radicals Chemical class 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000002140 halogenating effect Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
150000007529 inorganic bases Chemical class 0.000 description 2
125000000896 monocarboxylic acid group Chemical group 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
AFINAILKDBCXMX-PBHICJAKSA-N (2s,3r)-2-amino-3-hydroxy-n-(4-octylphenyl)butanamide Chemical compound CCCCCCCCC1=CC=C(NC(=O)[C@@H](N)[C@@H](C)O)C=C1 AFINAILKDBCXMX-PBHICJAKSA-N 0.000 description 1
SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
ZYBMAAOZXXKYTG-UHFFFAOYSA-N 1-phenylmethoxycarbonyldiazinane-3-carboxylic acid Chemical compound N1C(C(=O)O)CCCN1C(=O)OCC1=CC=CC=C1 ZYBMAAOZXXKYTG-UHFFFAOYSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
239000005541 ACE inhibitor Substances 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
239000007868 Raney catalyst Substances 0.000 description 1
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
229910000564 Raney nickel Inorganic materials 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
239000003377 acid catalyst Substances 0.000 description 1
125000002015 acyclic group Chemical group 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
238000004296 chiral HPLC Methods 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000006345 epimerization reaction Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
238000005984 hydrogenation reaction Methods 0.000 description 1
238000007327 hydrogenolysis reaction Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
239000003446 ligand Substances 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
125000005543 phthalimide group Chemical group 0.000 description 1
229960005235 piperonyl butoxide Drugs 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
102220030673 rs59931416 Human genes 0.000 description 1
150000003342 selenium Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000012265 solid product Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002500558A 2005-03-10 2005-03-10 Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril Abandoned CA2500558A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002500558A CA2500558A1 (fr)	2005-03-10	2005-03-10	Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002500558A CA2500558A1 (fr)	2005-03-10	2005-03-10	Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril

Publications (1)

Publication Number	Publication Date
CA2500558A1 true CA2500558A1 (fr)	2006-09-10

Family

ID=36998143

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002500558A Abandoned CA2500558A1 (fr)	2005-03-10	2005-03-10	Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril

Country Status (1)

Country	Link
CA (1)	CA2500558A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012049646A1 (fr)	2010-10-12	2012-04-19	Ranbaxy Laboratories Limited	Procédé de préparation d'un intermédiaire de cilazapril

2005
- 2005-03-10 CA CA002500558A patent/CA2500558A1/fr not_active Abandoned

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012049646A1 (fr)	2010-10-12	2012-04-19	Ranbaxy Laboratories Limited	Procédé de préparation d'un intermédiaire de cilazapril

Legal Events

Date	Code	Title	Description
2005-03-10	EEER	Examination request
2009-08-11	FZDE	Dead

Publication	Publication Date	Title
JP4994427B2 (ja)	2012-08-08	ピクテ−スペングラー反応の変法およびその産物
Jouin et al.	1987	Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid
KR102790077B1 (ko)	2025-04-03	칸나비노이드 수용체 2의 억제제로서 신규한 피리딘 및 피라진 화합물
KR20120014219A (ko)	2012-02-16	3-(치환된 디하이드로 이소인돌리논-2-일)-2,6-디옥소피페리딘의 합성 방법 및 그 중간체
JP2004525944A (ja)	2004-08-26	４，６−ジアミノピリミド［５，４−ｄ］ピリミジンを製造する方法
JP2691442B2 (ja)	1997-12-17	新規なプロリン誘導体
WO2014145507A1 (fr)	2014-09-18	Procédé de fabrication d'un analogue cyclique de peptide de 4-amino-4-oxobutanoyle, inhibiteur de réplication virale et leurs intermédiaires
Fauq et al.	1998	Synthesis of (2S)-2-amino-3-(1H-4-indolyl) propanoic acid, a novel tryptophan analog for structural modification of bioactive peptides
CA2500558A1 (fr)	2006-09-10	Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril
KR100691735B1 (ko)	2007-03-12	4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의신규한 제조 방법
JPH11349565A (ja)	1999-12-21	ピリドンカルボン酸誘導体の製造方法およびその中間体
EP1280780A2 (fr)	2003-02-05	Synthese asymetrique de l'acide piperazique et de derives de cet acide
AU776300B2 (en)	2004-09-02	Synthesis of 3-amino-3-aryl propanoates
KR20180118054A (ko)	2018-10-30	의약품 합성용 중간체 화합물의 제조 방법
JPS5833877B2 (ja)	1983-07-22	ユウキカゴウブツニカンスルカイリヨウ
Chacun-Lefevre et al.	2001	Intramolecular Heck coupling of alkenyl 3-iodoindole-2-carboxamide derivatives
US6197974B1 (en)	2001-03-06	Enantioselective synthesis of 3-aminopyrrolidines
ZA200500290B (en)	2005-11-14	Process for the preparation of amino-pyrrolidine derivatives.
CN120365245A (zh)	2025-07-25	一种瑞马唑仑中间体的制备方法
SU351369A1 (ru)		Способ получения алкалоидов
US5959141A (en)	1999-09-28	1-amino-2-hydroxycycloalkanecarboxylic acid derivatives
JP2003518124A (ja)	2003-06-03	ペプチドβ−ターン構造の模倣化合物及びその製法
CN120904158A (zh)	2025-11-07	奥比替布及其中间体的制备方法
Jones et al.	2002	A new 3-ethoxycarbonylisoxazolopyridone as a precursor to acylpyridones
Gavrielatos et al.	2002	Synthesis and spectroscopic studies of optically active n‐acetyl butenoates and n‐acetyl‐2‐alkyl‐pyrrolin‐4‐ones

CA2500558A1 - Methode de preparation de composes bicycliques du type aza et utilisation connexe desdits composes dans la synthese de cilazapril - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (1)

Family

ID=36998143

Family Applications (1)

Country Status (1)

Cited By (1)

Cited By (1)

Similar Documents

Legal Events